Selon une nouvelle étude, les récentes recommandations américaines en matière de dyslipidémie élargiraient les indications du traitement préventif par statines à 87,5 millions d'adultes américains. Publiées en mars, les recommandations multisociétales de ... See more
SAVANNAH, Ga. — Fat loss was among the most commonly reported complications associated with radiofrequency microneedling (RFMN) over the past 6-13 years, according to two new studies using data from the FDA’s Manufacturer and User Facility Device Experien... See more
A treatment protocol using fecal microbiota transplantation (FMT) improved objective sleep measures in adults with chronic insomnia disorder. Results of a small, randomized, double-blind, placebo-controlled trial showed that participants who received the ... See more
The FDA has approved centanafadine (Simtriyo, Otsuka) as a first-in-class treatment of attention-deficit/hyperactivity disorder (ADHD) in adult and pediatric patients. The once-daily extended-release capsule is approved for adults and children aged 6 year... See more
Newly released US dyslipidemia guidelines would expand recommendations for primary prevention statin therapy to 87.5 million US adults, new research suggested. Released in March, the 2026 American Heart Association/American College of Cardiology multisoci... See more
